Umberto Capitanio, MD, FEBU, department of Urology, San Raffaele Scientific Institute, University Vita-Salute San Raffaele, discusses adjuvant therapy for patients with high-risk kidney cancer without metastases.
Umberto Capitanio, MD
Advertisement
Articles by Umberto Capitanio, MD
Advertisement
Latest Updated Articles
Dr. Capitanio Discusses Adjuvant Therapy for High-Risk Kidney CancerNovember 19th 2017
Advertisement
Advertisement
Trending on OncLive
1
ctDNA Status Has Strong Prognostic Value, Outperforming pCR Status, in Early TNBC
2
Dato-DXd Hits Key Secondary Efficacy End Points in First-Line TNBC
3
Retrospective Data Show Zanubrutinib May Less AFib Burden in Real-World CLL
4
FDA Grants Priority Review to Giredestrant for ER-Positive Early Breast Cancer
5